Effect of progesterone and its synthetic analogues on the activity of mitochondrial permeability transition pore in isolated rat liver mitochondria

Biochemical Pharmacology

Volumn 78, Issue 8, 2009, Pages 1060-1068

  Fedotcheva, Nadezhda I ^a   Teplova, Vera V ^a   Fedotcheva, Tatiana A ^b   Rzheznikov, Vladimir M ^c   Shimanovskii, Nikolai L ^b  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Buterol; Medroxyprogesterone acetate; Mitochondrial permeability transition pore; Progesterone; Thiol groups

Indexed keywords

17A ACETOXY 3B BUTANOYLOXY 6 METHYLPREGNA 4,6 DIENE 20 ON; CALCIUM ION; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; PROGESTERONE DERIVATIVE; THIOL GROUP; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

17-ALPHA-HYDROXYPROGESTERONE; ANIMALS; CALCIUM; CELL MEMBRANE PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MEDROXYPROGESTERONE 17-ACETATE; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL SWELLING; MOLECULAR STRUCTURE; OXYGEN CONSUMPTION; RATS; RATS, WISTAR;

EID: 69349094915     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.05.028     Document Type: Article

References (52)

1. Gavrilova-Jordan L.P., and Price T.M. Actions of steroids in mitochondria. Semin Reprod Med 25 3 (2007) 154-164
2. Yager J.D., and Chen J.Q. Mitochondrial estrogen receptors-new insights into specific functions. Trends Endocrinol Metab 18 3 (2007) 89-91
3. Pedram A., Razandi M., Wallace D.C., and Levin E.R. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell 17 5 (2006) 2125-2137
4. Psarra A.M., and Sekeris C.E. Steroid and thyroid hormone receptors in mitochondria. IUBMB Life 60 4 (2008) 210-223
5. Araújo G.W., Beyer C., and Arnold S. Oestrogen influences on mitochondrial gene expression and respiratory chain activity in cortical and mesencephalic astrocytes. J Neuroendocrinol 20 7 (2008) 930-941
6. Irwin R.W., Yao J., Hamilton R.T., Cadenas E., Brinton R.D., and Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 149 6 (2008) 3167-3175
7. Mattingly K.A., Ivanova M.M., Riggs K.A., Wickramasinghe N.S., Barch M.J., and Klinge C.M. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol Endocrinol 22 3 (2008) 609-622
8. Scheller K., and Sekeris C.E. The effects of steroid hormones on the transcription of genes encoding enzymes of oxidative phosphorylation. Exp Physiol 88 1 (2003) 129-140
9. Boland R., Vasconsuelo A., Milanesi L., Ronda A.C., and de Boland A.R. 17beta-estradiol signaling in skeletal muscle cells and its relationship to apoptosis. Steroids 73 9-10 (2008) 859-863
10. Lin Y., Kokontis J., Tang F., Godfrey B., Liao S., Lin A., et al. Androgen and its receptor promote Bax-mediated apoptosis. Mol Cell Biol 26 5 (2006) 1908-1916
11. Razmara A., Sunday L., Stirone C., Wang X.B., Krause D.N., Duckles S.P., et al. Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells. J Pharmacol Exp Ther 325 3 (2008) 782-790
12. Cheng X., Shimizu I., Yuan Y., Wei M., Shen M., Huang H., et al. Effects of estradiol and progesterone on tumor necrosis factor alpha-induced apoptosis in human hepatoma HuH-7 cells. Life Sci 79 21 (2006) 1988-1994
13. Safiulina D., Peet N., Seppet E., Zharkovsky A., and Kaasik A. Dehydroepiandrosterone inhibits complex I of the mitochondrial respiratory chain and is neurotoxic in vitro and in vivo at high concentrations. Toxicol Sci 93 2 (2006) 348-356
14. Hagen T., D'Amico G., Quintero M., Palacios-Callender M., Hollis V., Lam F., et al. Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol. Biochem Biophys Res Commun 322 3 (2004) 923-929
15. Moreira P.I., Custódio J., Moreno A., Oliveira C.R., and Santos M.S. Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure. J Biol Chem 281 15 (2006) 10143-10152
16. Er F., Michels G., Gassanov N., Rivero F., and Hoppe U.C. Testosterone induces cytoprotection by activating ATP-sensitive K+ channels in the cardiac mitochondrial inner membrane. Circulation 110 19 (2004) 3100-3107
17. Swierczynski J., and Mayer D. Dehydroepiandrosterone-induced lipid peroxidation in rat liver mitochondria. J Steroid Biochem Mol Biol 58 5-6 (1996) 599-603
18. Katyare S.S., Modi H.R., and Patel M.A. Dehydroepiandrosterone treatment alters lipid/phospholipid profiles of rat brain and liver mitochondria. Curr Neurovasc Res 3 4 (2006) 273-279
19. Correa F., Garcia N., Garcia G., and Chavez E.J. Dehydroepiandrosterone as an inducer of mitochondrial permeability transition. Steroid Biochem Mol Biol 87 (2003) 279-284
20. Lu A., Frink M., Choudhry M.A., Schwacha M.G., Hubbard W.J., Rue III L.W., et al. Mitochondria play an important role in 17beta-estradiol attenuation of H(2)O(2)-induced rat endothelial cell apoptosis. Am J Physiol Endocrinol Metab 292 2 (2007) E585-E593
21. Felty Q., Xiong W.C., Sun D., Sarkar S., Singh K.P., Parkash J., et al. Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 44 18 (2005) 6900-6909
22. Miyaguchi C., Muranaka S., Kanno T., Fujita H., Akiyama J., Yoshioka T., et al. 17beta-estradiol suppresses ROS-induced apoptosis of CHO cells through inhibition of lipid peroxidation-coupled membrane permeability transition. Physiol Chem Phys Med NMR 36 1 (2004) 21-35
23. Wang X., Simpkins J.W., Dykens J.A., and Cammarata P.R. Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest Ophthalmol Vis Sci 44 5 (2003) 2067-2075
24. Singh M., Dykens J.A., and Simpkins J.W. Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med (Maywood) 231 5 (2006) 514-521
25. Starkov A.A., Simonyan R.A., Dedukhova V.I., Mansurova S.E., Palamarchuk L.A., and Skulachev V.P. Regulation of the energy coupling in mitochondria by some steroid and thyroid hormones. Biochim Biophys Acta 1318 1-2 (1997) 173-183
26. Fedotcheva NI, Kondrashova MN. Opposite effects of 6-ketocholestanol and dehydroepiandrosterone on the coupling of mitochondria. In: "Biological motility", Pushchino; 2008. p. 149-53.
27. Sergeev P.V., Semeǐkin A.V., Smirnova Z.S., Rzheznikov V.M., Grinenko G.S., Fedosov A.V., et al. Antitumor activity of the new gestagen 17alpha-acetoxy-3beta-butanoyloxy-6-methyl-pregna-4,6-dien-20-one. Eksp Klin Farmakol 67 4 (2004) 54-56 [Russian]
28. Sergeev P.V., Fedotcheva T.A., Rzheznikov V.M., Grinenko G.S., Semeǐkin A.V., Vetchinkina B., et al. A new Russian gestagen with anticancer activity. Vestn Ross Akad Med Nauk 5 (2007) 27-32 [Russian]
29. Pagnini U., Pacilio C., Florio S., Crispino A., Claudio P.P., Giordano A., et al. Medroxyprogesterone acetate increases anthracyclines uptake in chronic lymphatic leukemia cells: role of nitric oxide and lipid peroxidation. Anticancer Res 20 1A (2000) 33-42
30. Lindenmaier H., Becker M., Haefeli W.E., and Weiss J. Interaction of progestins with the human multidrug resistance-associated protein 2 (MRP2). Drug Metab Dispos 33 11 (2005) 1576-1579
31. Eden J. Progestins and breast cancer. Am J Obstet Gynecol 188 (2003) 1123-1131
32. Johnson D., and Lardy H.A. Isolation of liver or kidney mitochondria. Methods Enzymol 10 (1967) 94-96
33. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reaction. J Biol Chem 177 (1949) 751-766
34. Kamo N., Muratsugu M., Hongoh R., and Kobatake Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenylphosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Membr Biol 49 (1979) 105-121
35. Fedotcheva N.I., Kazakov R.E., Kondrashova M.N., and Beloborodova N.V. Toxic effects of microbial phenolic acids on the functions of mitochondria. Toxicol Lett 180 (2008) 182-188
36. Morkunaite-Haime S., Kruglov A., Teplova V., Stolze K., Gille L., Nohl H., et al. Reactive oxygen species are involved in the stimulation of the mitochondrial permeability transition by dihydrolipoate. Biochem Pharmacol 65 1 (2003) 43-49
37. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., and Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem 280 19 (2005) 18558-18561
38. Broekemeier K.M., Dempsey M.E., and Pfeiffer D.R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264 14 (1989) 7826-7830
39. McStay G.P., Clarke S.J., and Halestrap A.P. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem J 367 Pt 2 (2002) 541-548
40. Petronilli V., Costantini P., Scorrano L., Colonna R., Passamonti S., and Bernardi P. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J Biol Chem 269 24 (1994) 16638-16642
41. Costantini P., Chernyak B.V., Petronilli V., and Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 271 12 (1996) 6746-6751
42. Halestrap A.P., Woodfield K.Y., and Connern C.P. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 272 6 (1997) 3346-3354
43. Connern C.P., and Halestrap A.P. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem J 302 Pt 2 (1994) 321-324
44. Fedotcheva N.I., Sokolov A.P., and Kondrashova M.N. Nonenzymatic formation of succinate in mitochondria under oxidative stress. Free Radic Biol 41 (2006) 56-64
45. Leung A.W., and Halestrap A.P. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 1777 7-8 (2008) 946-952
46. Basso E., Petronilli V., Forte M.A., and Bernardi P. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation. J Biol Chem 283 39 (2008) 26307-26311
47. Halestrap A.P. What is the mitochondrial permeability transition pore?. J Mol Cell Cardiol 46 6 (2009) 821-831
48. Gabriel M.P., Storm J., Rothnie A., Taylor A.M., Linton K.J., Kerr I.D., et al. Communication between the nucleotide binding domains of P-glycoprotein occurs via conformational changes that involve residue 508. Biochemistry 42 25 (2003) 7780-7789
49. Higgins C.F., and Linton K.J. The ATP switch model for ABC transporters. Nat Struct Mol Biol 11 10 (2004) 918-926
50. Janas E., Hofacker M., Chen M., Gompf S., van der Does C., and Tampé R. The ATP hydrolysis cycle of the nucleotide-binding domain of the mitochondrial ATP-binding cassette transporter Mdl1p. J Biol Chem 278 29 (2003) 26862-26869
51. Rosenberg M.F., Velarde G., Ford R.C., Martin C., Berridge G., Kerr I.D., et al. Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle. EMBO J 20 20 (2001) 5615-5625
52. Loo T.W., and Clarke D.M. Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity. J Biol Chem 270 39 (1995) 22957-22961